EKB Journal Management System
1.

The Predictive Role of Key MAPK Pathway Variants in Differentiated Thyroid Cancer Patients’ Response to Radioactive Iodine Therapy

Volume 31, Issue 1, January 2025, Pages 543-554
Shaymaa E. El Feky; Tarek M. Salem; Omr S. Zahra; Magdi A. Ali; Ibrahim H. Abo El Azm; Hadeer M. Dosouky; Mohamed I. Morsi
2.

Nursing Guidelines on Safety Measures Awareness among Patients with Thyroid Disorders undergoing Radioactive Iodine Therapy

Volume 15, Issue 1, March 2024, Pages 1619-1633
Rasha Mohamed Elmetwaly; Asmaa Said Ali; Shimaa Nabil Abd Elsalam; Diaa Eldin Moussa Sherif; Somia Metwaly Elsayed
3.

From Hyperthyroidism to Hypothyroidism: A Detailed Analysis of Radioactive Iodine Therapy Outcomes Based on Dosage

Volume 12, Issue 1, January 2024, Pages 85-87
4.

Effect of Radioactive Iodine Therapy on Interleukin-2 (IL-2), IL-17 and Physiological Parameters in Iraqi Patients with Graves’ Disease

Volume 90, Issue 2, January 2023, Pages 3636-3640
Samara Assad Nafh; Rakad M. Kh AL-Jumaily
5.

Changes in Interleukin-35 (IL-35), Anti-TSHR antibody and Human Insulin- like Growth Factor 1 Receptor (IGF1R) in Graves’ Disease Patients Treatedwith Radioactive Iodine

Volume 90, Issue 2, January 2023, Pages 3730-3734
Samara Assad Nafh; Rakad M. Kh AL-Jumaily